col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


92 Results       Page 1

 [1] 
Bentham Science: Infectious Disorders - Drug Targets
  original article Date Title Authors   All Authors
1 [GO] 2022―Apr―29 Demographic, clinical, investigational characteristics of COVID-19 related Guillain-Barré syndrome with differences from typical and another virus-related Guillain-Barré syndrome Jitendra Singh, Nilesh Kumar, Anju Dinkar
2 [GO] 2022―Apr―26 ‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review Sumel Ashique, Tahamina Khatun, Garima Sahu, Aakash Upadhyay, Archana Adhana, Nitish Kumar, et al. (+2)
3 [GO] 2022―Apr―25 Infection and Severity of COVID-19 infection among health care workers: A report from Egypt Ehab F Moustafa, Sahar M Hassany, Asmaa Mohamed Ahmed Soliman, Mohammed Ezz-Eldin, Nariman Zaghloul, Sherief Abd-Elsalam
4 [GO] 2022―Apr―25 The emergence of Omicron SARS-CoV-2 variant (B.1.1.529) - the latest episode in the COVID-19 pandemic with a global riposte Suman Kumar Ray, Sukhes Mukherjee
5 [GO] 2022―Apr―22 Epigenetic-related effects of COVID-19 on the human cells Arezoo Faramarzi, Reza Safaralizadeh, Narges Dastmalchi, Shahram Teimourian
6 [GO] 2022―Apr―20 A clinically validated, broadly active, oral viral superinfection therapy could mitigate symptoms in early-stage COVID-19 patients Tibor Bakacs, Volker Sandig, Shimon Slavin, Serhat Gumrukcu, W David Hardy, Wolfgang Renz, Imre Kovesdi
7 [GO] 2022―Apr―20 Prevalence, presentation and outcome of secondary bloodstream infections among the COVID-19 patients Subhashree Samantaray, Priyabrat Karan, Anuradha Sharma, Vijayalakshmi Nag, Naveen Dutt, Mahendra Kumar Garg, et al. (+2)
8 [GO] 2022―Apr―20 COVID-19 vaccination, Peltzman Effect and possible increase in high-risk behaviors: a growing concern on risk compensation and reduced compliance to Public Health protective Measures after vaccines rollout Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, Iraj Pakzad, Ayoub Rashidi, Razi Naserifar, et al. (+2)
9 [GO] 2022―Apr―07 COVID-19 and Co-infections: A Serious Health Threat Requires Combination Diagnosis and Therapy Shahid Nawaz, Maira Saleem
10 [GO] 2022―Apr―07 SARS-CoV-2-Induced Neurological Disorders in Symptomatic Covid-19 and Long Covid Patients: Key Role of Brain Renin-Angiotensin System Ziad Fajloun, Hervé Kovacic, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Jean-Marc Sabatier
11 [GO] 2022―Apr―03 A new wave of COVID-19 in 2021 with unique genetic characters -present global scenario and beholding onwards Sukhes Mukherjee, Suman Kumar Ray
12 [GO] 2022―Mar―25 Technology in the Era of COVID-19: A Systematic Review of Current Evidence Esmaeil Mehraeen, Mohammad Mehrtak, SeyedAhmad SeyedAlinaghi, Zahra Nazeri, Amir Masoud Afsahi, Farzane Behnezhad, et al. (+6)
13 [GO] 2022―Mar―23 Therapeutic strategies for COVID-19 patients: An update Muhammad Ibrahim Getso, So�h Etemadi, Vahid Raissi, Moein Mohseni, Maedeh Sadat Mohseni, Farid Raeisi, Omid Raiesi
14 [GO] 2022―Mar―22 An update review on complicated mechanisms of COVID-19 pathogenesis and therapy: direct viral damage, renin-angiotensin system dysregulation, immune system derangements, and endothelial dysfunction Shahab Falahi, Maryam Maleki, Azra Kenarkoohi
15 [GO] 2022―Mar―22 An Insight of Clinical Evidences of Ayurveda Interventions in the Management of COVID-19 Patients Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramaniam, Gobinath Manavalan, Kumar Balasubramanian, Vasanth Kumar S
16 [GO] 2022―Mar―18 DO METHYLENE BLUE SATISFIES AN OPTION - IN COVID-19 ARDS Sri Hari TY, Sree Sudha TY, Krishna Sasanka KSBS, Pugazhenthan Thangaraju
17 [GO] 2022―Mar―18 Original antigenic sin in COVID-19: Hoskins effect and vaccine Mudassir Khan, Sobia Manzoor, Najeeb Ullah, Dilawar Khan
18 [GO] 2022―Feb―25 The Persistence Time of SARS-CoV-2 RNA in hospitalized COVID-19 Patients: A prospective Study Jila Yavarian, Mohammad Javaherian, Somayeh Shatizadeh Malekshahi, Zahra Ahmadinejad, Fatemeh Ghiasvand, Elaheh Ahmadi, et al. (+6)
19 [GO] 2022―Feb―22 Impact of tocilizumab on inflammatory markers and oxygen status in severe covid-19 patients: A single centre retrospective study. Abhishek Sharma, Deepak Nathiya, Supriya Suman, Hemant Bareth, Mahaveer Singh, Eshan Sharma
20 [GO] 2022―Feb―21 A Review on the New Indication of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in the Treatment of Coronavirus Disease 2019 Hedyieh Karbasforooshan, Sofia Salari, Hesamoddin Hosseinjani
21 [GO] 2022―Feb―16 Covid-19 Study, Pathology and Therapeutics Da-Yong Lu
22 [GO] 2022―Feb―09 Third waves of the COVID-19 pandemic: Prominence of initial public health Interference Sukhes Mukherjee, Suman Kumar Ray
23 [GO] 2022―Jan―28 Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19 Sara Torabi, Farbod Bahreini, Nima Rezaei
24 [GO] 2022―Jan―28 A case of multiple sclerosis with protracted course of COVID-19 Mehrdad Hasibi, Marjan Asadollahi, Ali Asadollahi-Amin
25 [GO] 2022―Jan―28 Diagnostic Stewardship in Times of Covid-19 Pandemic Lipika Singhal, Ivneet Kour, Varsha Gupta
26 [GO] 2022―Jan―24 An Overview of Antiviral Properties of Bacteriophages with Emphasis on the Treatment of COVID-19 Infection Mahsa Jalili, Nastaran Ansari, Behzad Pourhossein, Maryam Fazeli, Farid Azizi Jalilian
27 [GO] 2022―Jan―20 Molecular docking of phytochemical compounds of Momordica charantia as potential inhibitor against SARS-CoV-2 Yayu Mulsiani Evary, Ayu Masyita, Arie Ariezandi Kurnianto, Rangga Meidianto Asri, Yusnita Rifai
28 [GO] 2022―Jan―19 Ivermectin in COVID-19 Management: What is the current evidence? Madhavi Eerike, Gerard Marshall Raj, Rekha Priyadarshini, Gandham Ravi, Debasis Bisoi, Venu Gopala Rao Konda
29 [GO] 2022―Jan―18 Procalcitonin as a prognostic factor in patients with COVID-19 in southwestern Iran Milad Shahini Shams Abadi, Elham Taheri, Ahmad Raesi, Mohammad-Hassan Arjmand, Soleiman Kheirii, Najmeh Shahinfard, Zahra Habibi
30 [GO] 2022―Jan―18 Therapeutic Status of Famotidine in COVID-19 Patients: A Review Moein Mohseni, Vahid Raissi, Yasamin Sharifan, Kimia Barikro, Sasan Amiri, Maedeh Sadat Mohseni, et al. (+4)
31 [GO] 2022―Jan―18 Challenges in Engendering Herd Immunity to SARS-CoV-2 infection: Possibly Impossible but Plausibility with Hope Sukhes Mukherjee, Suman Kumar Ray
32 [GO] 2022―Jan―06 COVID-19 Infection in Pregnancy: A Review Sabrina Jahan Mily, Kazi Mahmuda Akter, Nowshin Jabin, Saikat Mitra, Talha Bin Emran, Monisha Nandi, et al. (+8)
33 [GO] 2022―Jan―06 The chance of COVID-19 infection after vaccination Ghazaleh Khalili-Tanha, Majid Khazaei, Saman Soleimanpour, Gordon A Ferns, Amir Avan
34 [GO] 2021―Dec―02 Case Report: Severe SARS-CoV-2 Infection with Remdesivir in a Patient with ESRD Raj H. Patel, Pablo M. Pella, Naeem Haider, Renato Blanco
35 [GO] 2021―Sep―30 COVID-19 in pediatrics: The current knowledge and practice Esmaeil Mehraeen, Shahram Oliaei, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, Amir Masoud Afsahi, et al. (+9)
36 [GO] 2021―Sep―23 Vaccines for COVID-19: A Review of Feasibility and Effectiveness Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, Amirali Karimi, Mehrzad MohsseniPour, Pegah Mirzapour, et al. (+11)
37 [GO] 2021―Sep―16 Liver injury in COVID-19: A Direct hit or Collateral damage? Balasubramaniyan Vairappan, Gavin Wright, Douglas Corrigal
38 [GO] 2021―Sep―13 Counter-Regulatory Renin-Angiotensin System: An Important Line of Research to Understand and Limit the Severity of COVID-19 Cédric Annweiler, Zhijian Cao, Nicolas Papon, Hervé Kovacic, Jean-Marc Sabatier
39 [GO] 2021―Sep―07 Persistent Hiccups as an Atypical Initial Presentation of COVID-19: A Case Report Omid Dadras, Alimohamad Asghari, Atefe Nosratzahi
40 [GO] 2021―Sep―06 SARS-CoV-2 transmission among health care workers in Iran: an urgent need for early identification and management Mohammad Reza Abdolsalehi, Shima Mahmoudi, Reza Shervin Badv, Babak Pourakbari, Keyvan Mirnia, Yasmine Mahmoudieh, Setareh Mamishi
41 [GO] 2021―Aug―30 DAMPening Severe COVID-19 with Dexamethasone Cédric Annweiler, Nicolas Papon, Jean-Marc Sabatier, Jean Barré
42 [GO] 2021―Aug―11 Can Antimalarial Phytochemicals be a Possible Cure for COVID-19? Molecular Docking Studies of Some Phytochemicals to SARS-CoV-2 3C-like Protease Anamul Hasan, Khoshnur Jannat, Tohmina Afroze Bondhon, Rownak Jahan, Md Shahadat Hossan, Maria de Lourdes Pereira, et al. (+3)
43 [GO] 2021―Jul―27 Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review Esmaeil Mehraeen, Zeinab Najafi, Bagher Hayati, Mohammad Javaherian, Sajad Rahimi, Omid Dadras, et al. (+3)
44 [GO] 2021―Jul―25 Genetics and Vaccine development for SARS-CoV2 in the era of Personalized Medicine Eirini Konstantina Tafanidou, Despoina Gkentzi
45 [GO] 2021―Jul―19 Shared Food, Meals and Drinks: 10 Arguments Suggesting an Oral Transmission Route of SARS-CoV-2 Jean-Michel Wendling, Aure Saulnier, Jean-Marc Sabatier
46 [GO] 2021―Jun―16 Hypothesis: Designation of Liposomal Scavenger System for Fighting against 2019-nCoV Nooshin Bagherani, Bruce R. Smoller
47 [GO] 2021―May―28 A short review on key role of plants and their extracts in boosting up immune response to combat COVID-19 Mudassir Khan, Muhammad Abu Bakar Saddique, Huzaifa Tahir, Muhammad Dawood Amjad, Abdullah Ahmad, Usama Masood, Dilawar Khan
48 [GO] 2021―Mar―23 Investigation of structural, treatment and clinical characteristics of COVID-19 along with the challenges caused by its prevalence Maham Doagooyan, Seyedeh Hoda Alavizadeh, Javad Akhtari, Amirhossein Sahebkar, Saeed Ghanbari Hasan Kiade, Pariya Haghgoo Kochesfahani, Fatemeh Gheybi
49 [GO] 2021―Mar―03 COVID-19 and Infectious Disease Speciality - A necessity of Time in India. Gopal K Bohra, Deepak Kumar, Mahendra K Garg
50 [GO] 2021―Mar―03 The recovery of an elderly woman with asthma and diabetes from COVID-19 infection: a case report Abas Ghaysouri, Maryam Safari, Elham Mohammadyari, Firooz Balavandi, Ali Nazari, Jalil Feizi, et al. (+4)
51 [GO] 2021―Mar―01 A mini review on the pathogenesis, diagnosis and treatment options for COVID-19 Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A Ferns, Majid Khazaei, Soodabeh Shahidsales, Amir Avan
52 [GO] 2021―Mar―01 COVID-19: Potential Repurposing Drugs Wattana Leowattana
53 [GO] 2021―Feb―19 COVID-19 and Neurology - An Emerging Association Amit Gupta, Prakrati Yadav, Deepak Kumar
54 [GO] 2021―Feb―19 Natural Derived Nasal Spray; a Proposed Approach for COVID-19 Disease Control Zahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Ahmad-Reza Soroush, Zahra Sajjadpour, Shirin Hasani-Ranjbar, Bagher Larijani
55 [GO] 2021―Feb―19 Hepatic involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran Ahmad Hormati, Mohammad Reza Ghadir, Mohammad Saeidi, Reza Aminnejad, Mahboubeh Afifian, Sajjad Ahmadpour
56 [GO] 2021―Feb―04 COVID-19 and Alcohol Misuse: A Case Report Ali Asadollahi-Amin, Ali Nowroozi, Mehrdad Hasibi, Behzad Asanjarani, SeyedAhmad SeyedAlinaghi
57 [GO] 2021―Feb―04 Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a patient with Hodgkin's lymphoma history from north of Iran David Darvishnia, Mahdieh Sadeghi, Ali Sharifpour, Zakaria Zakariaei, Elham Sadat Banimostafavi, Mahdi Fakhar, Rabeeh Tabaripour
58 [GO] 2021―Jan―19 The Role of Justicia Adhatoda as prophylaxis for COVID-19 - Analysis based on docking study Pugazhenthan Thangaraju, Sree Sudha TY, Praveen Kumar Pasala, Sri Hari TY, Sajitha Venkatesan, Eswaran Thangaraju
59 [GO] 2021―Jan―05 SARS-CoV-2: An insight into detection tools Shaghayegh Khanmohammadi, Mohammadreza Tabary, Farnaz Araghi, Seyed Mohammad Tavangar
60 [GO] 2021―Jan―05 Modifications of Medical Care of Chronic Liver Diseases during COVID19 Pandemic: Necessity or Novelty? Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem, Sherief Abd-Elsalam
61 [GO] 2021―Jan―04 An Updated Review on COVID-19 Mahmoud Ahmed Ebada, Ahmed Wadaa Allah, Eshak Bahbah, Ahmed Negida
62 [GO] 2020―Dec―21 Pharmacological strategies for COVID-19 - A review of the most promising repurposed antiviral drugs. Deepti Chopra, Jaspreet K Boparai, Bharti Bhandari, Anurag Srivastava, Rakesh Gupta
63 [GO] 2020―Dec―21 Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker Tarun Sharma, Sidharth Mehan
64 [GO] 2020―Dec―10 Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mehrnaz Asadi Gharabaghi, Fereshteh Ghiasvand
65 [GO] 2020―Dec―10 Coronavirus Disease 2019: Virology and Drug Targets Praveen Thaggikuppe Krishnamurthy
66 [GO] 2020―Dec―08 Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study Milon Mondal, Chandan Sarkar, Sarmin Jamaddar, Abul Bashar Ripon Khalipha, Muhammad Torequl Islam, Azmi Mahafzah, Mohammad S. Mubarak
67 [GO] 2020―Nov―27 COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases Fereshteh Ghiasvand, Maryam Ghadimi, Sara Sadr, Fatemeh Jafari, Navid Manafi, Zahra Ah-madinejad, et al. (+2)
68 [GO] 2020―Nov―17 Pharmacological inhibition of MMP3 as a potential therapeutic option for COVID-19 associated acute respiratory distress syndrome Rana Kadry, Andrea Sikora Newsome, Payaningal R. Somanath
69 [GO] 2020―Nov―17 A Patient with COVID-19 Pneumonia Presenting with Plural Effusion: A Case Report. Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi, Samaneh Tirgar, Mohamad Reza Salehi, Banafsheh Moradmand-Badie
70 [GO] 2020―Nov―17 Transmission Modes of COVID-19: A Systematic Review Esmaeil Mehraeen, Mohammad Amin Salehi, Farzane Behnezhad, Hamed Rezakhani Moghaddam, SeyedAhmad SeyedAlinaghi
71 [GO] 2020―Nov―13 Postoperative COVID-19 pneumonia in an asymptomatic patient: a case report Ali Asadollahi-Amin, Elnaz Shahmohamadi, Mehrdad Hasibi, Maryam Moosivand, Maryam Taghizadeh, Seyed Ahmad Seyed Alinaghi
72 [GO] 2020―Nov―10 An overview on COVID-19 pandemic: from discovery to treatment Kalpana Panati, Venkatramana Reddy Arva Tatireddygari, Venkata Ramireddy Narala
73 [GO] 2020―Oct―30 Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review Timotius Ivan Hariyanto, Elizabeth Kristine, Catherine Jillian Hardi, Andree Kurniawan
74 [GO] 2020―Oct―20 A Viewpoint On Potential Biomarkers For Infectious COVID-19 severity: An Updated Literature Survey Suraj N. Mali, Fatemeh Mohajer, Ghodsi Mohammadi Ziarani, Amit P. Pratap
75 [GO] 2020―Oct―18 BCG vaccine, a ray of hope in treating Severe Acute Respiratory Syndrome (SARS) Amit Bandyopadhyay Banerjee, Thakur Gurjeet Singh, Abhimanyu Prashar
76 [GO] 2020―Oct―14 COVID-19 And Type 2 Diabetes Mellitus: Hydroxychloroquine May Be The Holy Grail Rimesh Pal, Manoj K. Bhasin, Sanjay K. Bhadada
77 [GO] 2020―Oct―07 Covid-19, SARS -CoV-2, Origin, transmission and treatment aspects, a brief review Shahid Nawaz
78 [GO] 2020―Sep―22 Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction Nahid Akhtar, Amit Joshi, Bhupender Singh, Vikas Kaushik
79 [GO] 2020―Sep―05 Impact of COVID-19 on Indian Pharmaceutical Industry and WayForward Nikita Vijay Jadhav, Nisha Singh, Monika Targhotra, Meenakshi K. Chauhan
80 [GO] 2020―Aug―05 Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein Bipin Singh
81 [GO] 2020―Jul―30 Ocular COVID-19: Eyes as a reservoir to conceal and spread SARS-CoV-2 Abdul Mannan Baig, Saara Ahmad, Areeba Khaleeq, Hamna Rafique, Shafiqa Rajput, Mehaer Angez, et al. (+3)
82 [GO] 2020―Jul―28 In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases Trinath Chowdhury, Gourisankar Roymahapatra, Santi M. Mandal
83 [GO] 2020―Jul―27 Chloroquine as chemoprophylaxis for COVID-19: Will this work? Sherief Abd-Elsalam, Mahmoud Elkadeem, Khadija Ahmed Glal
84 [GO] 2020―Jul―21 Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis. Tommy Richard Sun-Wing TONG
85 [GO] 2020―Jun―22 Targeting infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) applications: Evidence based opinion Suraj N. Mali, Amit P. Pratap
86 [GO] 2020―Jun―09 Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report Zahra Ahmadinejad, Faeze Salahshour, Omid Dadras, Hesan Rezaei, SyyedAhmad Alinaghi
87 [GO] 2020―May―21 Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi
88 [GO] 2020―May―20 SARS-CoV-2: The Path of Prevention and Control Amal A. Mohamed, Nouran Mohamed, Seham Mohamoud, Fawkia E. Zahran, Rania Abdelmonem Khattab, Dalia Ali El-Damasy, et al. (+2)
89 [GO] 2020―May―18 Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients Cédric Annweiler, Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Stéphanie Mouhat, Hervé Kovacic, Jean-Marc Sabatier
90 [GO] 2020―May―11 A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19) Suraj N. Mali, Bapu R. Thorat, Atul R. Chopade
91 [GO] 2020―May―06 SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Jean-Marc Sabatier
92 [GO] 2020―Apr―29 A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan, Seyed Ahmad Seyed Alinaghi
 [1] 

92 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec